The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Amph  -  amphiphysin

Rattus norvegicus

Synonyms: Amph1, Amphiphysin
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Amph1

  • Dephosphorylation of amphiphysin I requires extracellular Ca2+ and is unaffected by pretreatment of synaptosomes with tetanus toxin [1].
  • Improved antifungal activity and reduced toxicity of Amph B solubilized in MM may be due to higher cellular uptake of the drug by fungal cells of infected tissues from MM formulations [2].
  • The authors report a 71-year-old woman with amphiphysin-associated paraneoplastic stiff-person syndrome, opsoclonus, and encephalopathy [3].
 

Psychiatry related information on Amph1

 

High impact information on Amph1

  • Synaptojanin is the only other major brain protein besides dynamin that binds the SH3 domain of amphiphysin, a presynaptic protein with a putative function in endocytosis [6].
  • Phosphorylation was proposed to regulate the assembly of an endocytic protein complex with amphiphysin or endophilin [7].
  • Pseudophosphorylation of Ser-774 or Ser-778 inhibited syndapin binding without affecting amphiphysin recruitment [7].
  • Capacitance measurements of membrane retrieval were made in terminals in which peptides and protein domains were introduced to disrupt known interactions of clathrin, the AP2 adaptor complex, and amphiphysin [8].
  • A major physiological binding partner for dynamin I and synaptojanin in the nervous system is amphiphysin I, an SH3 domain-containing protein also concentrated in nerve terminals [9].
 

Biological context of Amph1

  • Like Amph1, a role in endocytosis at the nerve terminal is supported by the rapid dephosphorylation of Amph2 on depolarization [10].
  • However, when Mnbk/Dyrk1A phosphorylation was allowed to proceed more extensively, the phosphorylation enhanced rather than reduced the binding of dynamin 1 to amphiphysin 1 [11].
  • We hypothesize that the parallel Ca2+-dependent calcineurin-dependent dephosphorylation of amphiphysin I and of its two major binding proteins is part of a process that primes the nerve terminal for endocytosis in response to a burst of exocytosis [1].
  • Accumulations of amphiphysin and synaptojanin immunoreactivities at the crush site were detected as short as 1 h after the lesion, indicating that a pool of these two partially cytosolic proteins moves along the axon by fast axoplasmic transport [12].
  • Expression of a mutant amphiphysin harboring two amino acid substitutions in the SH3 domain, and therefore unable to bind proline-containing motifs, induces an accumulation of large intracellular aggregates including amphiphysin, clathrin, AP-2, and other endocytic proteins, as well as a concomitant block of transferrin endocytosis [13].
 

Anatomical context of Amph1

 

Associations of Amph1 with chemical compounds

  • Dephosphorylation of amphiphysin I, like dephosphorylation of dynamin I and synaptojanin I, is inhibited by cyclosporin A and FK-506 (0.5 microM), two drugs that specifically block the Ca2+/calmodulin-dependent phosphatase 2B calcineurin, but not by okadaic acid (1 microM), which blocks protein phosphatases 1 and 2B [1].
  • Synaptojanin is a nerve-terminal enriched inositol 5-phosphatase thought to function in synaptic vesicle endocytosis, in part through interactions with the Src homology 3 domain of amphiphysin [16].
  • In adult testes reversibly damaged by ethane dimethane sulphonate administration, expression of amphiphysin I did not change following the damage, whereas the protein was transiently converted into its phosphorylated form [17].
  • The MM formulations of Amph B were prepared using sodium deoxycholate (NDC)/sodium taurocholate (NTC)/sodium cholate (NC), and HSPC [2].
  • The purpose of the study was to develop a stable, controlled release Amphotericin B (Amph B) lyophilized mixed micelle (MM) formulation using hydrogenated soya phosphatidylcholine (HSPC) and bile salts in monomeric form and evaluate it for therapeutic performance and side effects [2].
 

Regulatory relationships of Amph1

 

Other interactions of Amph1

 

Analytical, diagnostic and therapeutic context of Amph1

  • The presence of amphiphysin-1 and -2 RNAs was revealed by RT-PCR and a new splice variant of amphiphysin-2 was detected [14].
  • By immunoprecipitation and double-immunolabelling, amphiphysin Ir was shown to be associated not only with amphiphysin II, but also with dynamin, clathrin and alpha-adaptin that are involved in synaptic vesicle recycling [20].
  • Cellular distribution of Amph was visualized with confocal immunofluorescence microscopy performed using the labeled-mAbs [21].
  • Western blot analysis revealed that amphiphysin I levels steadily increased with neuronal differentiation, whereas in antisense-treated cultures amphiphysin I levels were reduced to approximately 10% of control levels at 48 hr [15].

References

  1. Amphiphysin I is associated with coated endocytic intermediates and undergoes stimulation-dependent dephosphorylation in nerve terminals. Bauerfeind, R., Takei, K., De Camilli, P. J. Biol. Chem. (1997) [Pubmed]
  2. Development of novel lyophilized mixed micelle amphotericin B formulation for treatment of systemic fungal infection. Naik, S., Chougule, M., Padhi, B.K., Misra, A. Current drug delivery. (2005) [Pubmed]
  3. Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Wessig, C., Klein, R., Schneider, M.F., Toyka, K.V., Naumann, M., Sommer, C. Neurology (2003) [Pubmed]
  4. Electroconvulsive shock increases the phosphorylation of amphiphysin II in the rat cerebellum. Koo, Y.J., Kim, S.J., Jeon, S.H., Kim, S.R., Kang, U.G., Park, J.B., Kim, Y.S. Neurosci. Lett. (2002) [Pubmed]
  5. Sleep deprivation-induced protein changes in basal forebrain: implications for synaptic plasticity. Basheer, R., Brown, R., Ramesh, V., Begum, S., McCarley, R.W. J. Neurosci. Res. (2005) [Pubmed]
  6. A presynaptic inositol-5-phosphatase. McPherson, P.S., Garcia, E.P., Slepnev, V.I., David, C., Zhang, X., Grabs, D., Sossin, W.S., Bauerfeind, R., Nemoto, Y., De Camilli, P. Nature (1996) [Pubmed]
  7. Syndapin I is the phosphorylation-regulated dynamin I partner in synaptic vesicle endocytosis. Anggono, V., Smillie, K.J., Graham, M.E., Valova, V.A., Cousin, M.A., Robinson, P.J. Nat. Neurosci. (2006) [Pubmed]
  8. Clathrin-dependent and clathrin-independent retrieval of synaptic vesicles in retinal bipolar cells. Jockusch, W.J., Praefcke, G.J., McMahon, H.T., Lagnado, L. Neuron (2005) [Pubmed]
  9. The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain. Ringstad, N., Nemoto, Y., De Camilli, P. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  10. Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Wigge, P., Köhler, K., Vallis, Y., Doyle, C.A., Owen, D., Hunt, S.P., McMahon, H.T. Mol. Biol. Cell (1997) [Pubmed]
  11. Dynamin is a minibrain kinase/dual specificity Yak1-related kinase 1A substrate. Chen-Hwang, M.C., Chen, H.R., Elzinga, M., Hwang, Y.W. J. Biol. Chem. (2002) [Pubmed]
  12. Intraneuronal trafficking and distribution of amphiphysin and synaptojanin in the rat peripheral nervous system and the spinal cord. Li, J.Y., De Camilli, P., Dahlström, A. Eur. J. Neurosci. (1997) [Pubmed]
  13. A putative role for intramolecular regulatory mechanisms in the adaptor function of amphiphysin in endocytosis. Farsad, K., Slepnev, V., Ochoa, G., Daniell, L., Haucke, V., De Camilli, P., Hauke, V. Neuropharmacology (2003) [Pubmed]
  14. Expression of the endocytic proteins dynamin and amphiphysin in rat gastric enterochromaffin-like cells. Zanner, R., Gratzl, M., Prinz, C. J. Cell. Sci. (2004) [Pubmed]
  15. Amphiphysin I antisense oligonucleotides inhibit neurite outgrowth in cultured hippocampal neurons. Mundigl, O., Ochoa, G.C., David, C., Slepnev, V.I., Kabanov, A., De Camilli, P. J. Neurosci. (1998) [Pubmed]
  16. Identification of the major synaptojanin-binding proteins in brain. de Heuvel, E., Bell, A.W., Ramjaun, A.R., Wong, K., Sossin, W.S., McPherson, P.S. J. Biol. Chem. (1997) [Pubmed]
  17. Expression of amphiphysin I in Sertoli cells and its implication in spermatogenesis. Watanabe, M., Tsutsui, K., Hosoya, O., Tsutsui, K., Kumon, H., Tokunaga, A. Biochem. Biophys. Res. Commun. (2001) [Pubmed]
  18. Calcium triggers calcineurin-dependent synaptic vesicle recycling in mammalian nerve terminals. Marks, B., McMahon, H.T. Curr. Biol. (1998) [Pubmed]
  19. Mechanisms of dense core vesicle recapture following "kiss and run" ("cavicapture") exocytosis in insulin-secreting cells. Tsuboi, T., McMahon, H.T., Rutter, G.A. J. Biol. Chem. (2004) [Pubmed]
  20. Localized expression of amphiphysin Ir, a retina-specific variant of amphiphysin I, in the ribbon synapse and its functional implication. Hosoya, O., Tsutsui, K., Tsutsui, K. Eur. J. Neurosci. (2004) [Pubmed]
  21. Production and characterization of monoclonal antibodies against amphiphysins. Jin, Y., Kim, K.Y., Soung, N.K., Shin, E.Y., Kim, E.G., Kim, S.R. Exp. Mol. Med. (2001) [Pubmed]
 
WikiGenes - Universities